Pharmaceutical-industry

Do you have an idea for The New Times to cover? Submit it here!
Search Results for "Pharmaceutical-industry" (267 articles)
State Minister for Education, Claudette Irere, said the Covid-19 pandemic revealed critical gaps in Africa’s preparedness. Photos by Craish BAHIZI
Featured

East Africa joins forces to bridge vaccine gap, fortify health security

Monday, March 02, 2026
Ahmed Rady - Managing Director at Admaius (Egypt)
Featured

PRESS RELEASE: Admaius Capital Partners announces successful exit from Parkville Pharmaceuticals

Tuesday, January 27, 2026
Training sessions at ACES are delivered with a strong focus on Gender Equality and Social Inclusion (GESI).

Empowerment in action: Strengthening communities through training

Tuesday, December 30, 2025
Dr Jerome Kim, Director General of the International Vaccine Institute (IVI), speaks with The New Times journalist during an interview in Kigali on November 14. Photos by Craish Bahizi.
Health

What it takes to build vaccine manufacturing capacity in emerging markets

Saturday, November 15, 2025
Yarub Qudah, Jordan’s minister of industry (Left) and Jane Arakwiye, Rwanda’s minister of environment after signing one of the agreements. Photo by RDB media.
Economy

Rwanda, Jordan sign agreements on trade, investment

Thursday, October 09, 2025
Minister of Health, Dr. Sabin Nsanzimana, inspects medicines manufactured by Labophar during his tour in Huye District on September 8. Courtesy
Health

Drug maker Labophar in new drive to boost Rwanda’s access to essential medicines

Friday, October 03, 2025
Patients at Munini Hospital in Nyaruguru sit waiting to be assisted. In July 2025, the government introduced a new pricing structure for medical services in private healthcare facilities the first major tariff revision since 2014. File Photo.
Health

How revised medical tariffs are reshaping healthcare access

Friday, August 01, 2025
A pharmacist holds a vial of lenacapavir , at the Desmond Tutu Health Foundation's Masiphumelele Research Site, in Cape Town, South Africa. Gilead Sciences and the Global Fund, under the ‘Global Fund partnership’, recently made a deal to supply Lenacapavir at ‘no profit’ to countries supported by the fund, including Rwanda. Photo: Internet.
Health

How can Rwandans acquire new HIV preventive drug at a lower price?

Wednesday, July 23, 2025
The New Times
Health

IVI Africa’s Ndembi on Rwanda’s role in vaccine innovation and health security

Monday, July 21, 2025
According to the 2024 Trade and Industry Performance report, Rwanda’s top 10 imports were valued at over $1.95 billion (approximately Rwf2.8 trillion). Photo by RwandAir
Economy

A look at Rwanda’s top 10 imports valued at Rwf2.8tn

Monday, July 21, 2025
A health worker prepares an injection of lenacapavir. a new long-acting HIV prevention drug that could revolutionize access to HIV protection, especially in Africa, where such medication has historically been hard to access. Photo- Courtesy
Editorial

New drug offers hope against HIV, now the world must act

Friday, July 18, 2025
Delegates at during the Rwanda Convention 2025 event held in Dallas, Texas
International

USA: Rwandan diaspora homecoming set for August 2026

Sunday, July 06, 2025